Home > Insider Trading > Filing (0001628280-19-014431)

Filing Details

Accession Number:: 0001628280-19-014431
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-11-21 18:30:20
Reporting Period:: 2019-11-19

Accepted Time:: 2019-11-21 18:30:20
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1576280	Guardant Health Inc.	GH	Services-Medical Laboratories (8071)	454139254

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1753159	Amirali Talasaz	505 Penobscot Drive Redwood City CA 94063	Chairman, President And Coo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2019-11-06	902	$0.00	72,321	No	5	G	Direct
Common Stock	Acquisiton	2019-11-06	451	$0.00	9,974	No	5	G	Indirect	Shares held by Samar Talasaz 2018 Irrevocable Trust
Common Stock	Acquisiton	2019-11-06	451	$0.00	9,974	No	5	G	Indirect	Shares held by Sana Talasaz 2018 Irrevocable Trust
Common Stock	Acquisiton	2019-11-19	26,782	$4.18	99,103	No	4	M	Direct
Common Stock	Disposition	2019-11-19	1,045	$76.85	98,058	No	4	S	Direct
Common Stock	Disposition	2019-11-19	4,629	$77.81	93,429	No	4	S	Direct
Common Stock	Disposition	2019-11-19	21,176	$78.78	72,253	No	4	S	Direct
Common Stock	Disposition	2019-11-19	201	$79.21	72,052	No	4	S	Direct
Common Stock	Disposition	2019-11-19	2,929	$76.85	3,600,467	No	4	S	Indirect	Shares held by Talasaz and Eskandari 2017 Family Trust
Common Stock	Disposition	2019-11-19	12,948	$77.81	3,587,519	No	4	S	Indirect	Shares held by Talasaz and Eskandari 2017 Family Trust
Common Stock	Disposition	2019-11-19	59,244	$78.78	3,528,275	No	4	S	Indirect	Shares held by Talasaz and Eskandari 2017 Family Trust
Common Stock	Disposition	2019-11-19	567	$79.21	3,527,708	No	4	S	Indirect	Shares held by Talasaz and Eskandari 2017 Family Trust
Common Stock	Disposition	2019-11-19	76	$76.85	9,898	No	4	S	Indirect	Shares held by Samar Talasaz 2018 Irrevocable Trust
Common Stock	Disposition	2019-11-19	356	$77.81	9,542	No	4	S	Indirect	Shares held by Samar Talasaz 2018 Irrevocable Trust
Common Stock	Disposition	2019-11-19	1,586	$78.79	7,956	No	4	S	Indirect	Shares held by Samar Talasaz 2018 Irrevocable Trust
Common Stock	Disposition	2019-11-19	17	$79.21	7,939	No	4	S	Indirect	Shares held by Samar Talasaz 2018 Irrevocable Trust
Common Stock	Disposition	2019-11-19	76	$76.85	9,898	No	4	S	Indirect	Shares held by Sana Talasaz 2018 Irrevocable Trust
Common Stock	Disposition	2019-11-19	356	$77.81	9,542	No	4	S	Indirect	Shares held by Sana Talasaz 2018 Irrevocable Trust
Common Stock	Disposition	2019-11-19	1,586	$78.79	7,956	No	4	S	Indirect	Shares held by Sana Talasaz 2018 Irrevocable Trust
Common Stock	Disposition	2019-11-19	17	$79.21	7,939	No	4	S	Indirect	Shares held by Sana Talasaz 2018 Irrevocable Trust
Common Stock	Acquisiton	2019-11-20	17,231	$4.18	89,283	No	4	M	Direct
Common Stock	Disposition	2019-11-20	420	$78.54	88,863	No	4	S	Direct
Common Stock	Disposition	2019-11-20	12,144	$79.13	76,719	No	4	S	Direct
Common Stock	Disposition	2019-11-20	4,840	$79.97	71,879	No	4	S	Direct
Common Stock	Disposition	2019-11-20	1,184	$78.54	3,526,524	No	4	S	Indirect	Shares held by Talasaz and Eskandari 2017 Family Trust
Common Stock	Disposition	2019-11-20	33,965	$79.13	3,492,559	No	4	S	Indirect	Shares held by Talasaz and Eskandari 2017 Family Trust
Common Stock	Disposition	2019-11-20	13,547	$79.97	3,479,012	No	4	S	Indirect	Shares held by Talasaz and Eskandari 2017 Family Trust
Common Stock	Disposition	2019-11-20	33	$78.54	7,906	No	4	S	Indirect	Shares held by Samar Talasaz 2018 Irrevocable Trust
Common Stock	Disposition	2019-11-20	910	$79.12	6,996	No	4	S	Indirect	Shares held by Samar Talasaz 2018 Irrevocable Trust
Common Stock	Disposition	2019-11-20	367	$79.97	6,629	No	4	S	Indirect	Shares held by Samar Talasaz 2018 Irrevocable Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	5	G	Direct
No	5	G	Indirect	Shares held by Samar Talasaz 2018 Irrevocable Trust
No	5	G	Indirect	Shares held by Sana Talasaz 2018 Irrevocable Trust
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Indirect	Shares held by Talasaz and Eskandari 2017 Family Trust
No	4	S	Indirect	Shares held by Talasaz and Eskandari 2017 Family Trust
No	4	S	Indirect	Shares held by Talasaz and Eskandari 2017 Family Trust
No	4	S	Indirect	Shares held by Talasaz and Eskandari 2017 Family Trust
No	4	S	Indirect	Shares held by Samar Talasaz 2018 Irrevocable Trust
No	4	S	Indirect	Shares held by Samar Talasaz 2018 Irrevocable Trust
No	4	S	Indirect	Shares held by Samar Talasaz 2018 Irrevocable Trust
No	4	S	Indirect	Shares held by Samar Talasaz 2018 Irrevocable Trust
No	4	S	Indirect	Shares held by Sana Talasaz 2018 Irrevocable Trust
No	4	S	Indirect	Shares held by Sana Talasaz 2018 Irrevocable Trust
No	4	S	Indirect	Shares held by Sana Talasaz 2018 Irrevocable Trust
No	4	S	Indirect	Shares held by Sana Talasaz 2018 Irrevocable Trust
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Indirect	Shares held by Talasaz and Eskandari 2017 Family Trust
No	4	S	Indirect	Shares held by Talasaz and Eskandari 2017 Family Trust
No	4	S	Indirect	Shares held by Talasaz and Eskandari 2017 Family Trust
No	4	S	Indirect	Shares held by Samar Talasaz 2018 Irrevocable Trust
No	4	S	Indirect	Shares held by Samar Talasaz 2018 Irrevocable Trust
No	4	S	Indirect	Shares held by Samar Talasaz 2018 Irrevocable Trust

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	STOCK OPTION (RIGHT TO BUY)	Disposition	2019-11-19	26,782	$0.00	26,782	$4.18
Common Stock	STOCK OPTION (RIGHT TO BUY)	Disposition	2019-11-20	17,231	$0.00	17,231	$4.18

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
983,299		2022-07-13	No	4	M	Direct
966,068		2022-07-13	No	4	M	Direct

Footnotes

These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
Some of the shares sold were acquired contemporaneously upon the cashless exercise of stock options at an exercise price of $4.18 per share.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $76.13 to $77.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $77.13 to $78.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $78.17 to $79.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $79.17 to $79.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $77.78 to $78.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $78.78 to $79.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $79.78 to $80.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on April 23, 2017.